C07F 9/65031
Having the nitrogen atoms in the positions 1 and 2
Official title: {having the nitrogen atoms in the positions 1 and 2}
C07F9/65031 (Having the nitrogen atoms in the positions 1 and 2) appears on 178 US grants and 141 published applications in this corpus.
Search patents in C07F- Granted patents
- 178
- Published applications
- 141
- Assignees
- 106
- Inventors
- 614
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 1 | 0 |
| 1987 | 3 | 0 |
| 1988 | 4 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 4 | 0 |
| 1992 | 1 | 0 |
| 1993 | 4 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 3 | 0 |
| 1997 | 1 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 4 | 0 |
| 2002 | 4 | 2 |
| 2003 | 2 | 2 |
| 2004 | 1 | 4 |
| 2005 | 2 | 5 |
| 2006 | 0 | 6 |
| 2007 | 3 | 7 |
| 2008 | 7 | 9 |
| 2009 | 5 | 5 |
| 2010 | 8 | 7 |
| 2011 | 4 | 3 |
| 2012 | 7 | 5 |
| 2013 | 3 | 6 |
| 2014 | 6 | 8 |
| 2015 | 12 | 7 |
| 2016 | 10 | 11 |
| 2017 | 7 | 12 |
| 2018 | 4 | 3 |
| 2019 | 8 | 6 |
| 2020 | 4 | 5 |
| 2021 | 4 | 3 |
| 2022 | 3 | 6 |
| 2023 | 4 | 4 |
| 2024 | 5 | 6 |
| 2025 | 2 | 5 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Immunomodulator8 Sep 2026US 12,729,195 B2Hitgen Inc.
- Compounds for treating conditions related to oxidative stress4 Nov 2025US 12,459,900 B2
- Quinone methide analog signal amplification4 Feb 2025US 12,215,118 B2Ventana Medical Systems, Inc.
- Phosphohistidine mimetics and antibodies to same17 Dec 2024US 12,168,671 B2The Trustees of Princeton University
- Quinoline cGAS antagonist compounds5 Nov 2024US 12,134,609 B2Board of Regents, The University of Texas System
- Inhibitors of myc and uses thereof17 Sep 2026US 2026/0274827 A1Northwestern University
- Gip receptor agonist compounds23 Apr 2026US 2026/0108546 A1Eli Lilly and Company
- Inhibitors of myc and uses thereof5 Feb 2026US 2026/0035360 A1Northwestern University
- Electrochemical synthesis of pyrazolines and pyrazoles8 Jan 2026US 2026/0009142 A1Bayer Aktiengesellschaft
- Phosphorus compound and use thereof2 Oct 2025US 2025/0304608 A1Shanghai Shijiang Biotechnology Co., Ltd
Most cited
By later US patents
- Substituted alkanediphosphonic acids and pharmaceutical use159US 4,939,130 ACiba-Geigy Corporation · 1990
- Organophosphorus derivatives of indazoles and use thereof as medicinal products90US 7,491,710 B2Aventis Pharma S. A. · 2009
- Phosphonic acid derivatives65US 5,719,303 AEisai Co., Ltd. · 1998
- Neprilysin inhibitors51US 9,108,934 B2Theravance Biopharma R&D IP, LLC · 2015
- Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus50US 8,211,923 B2Boehringer Ingelheim International GmbH · 2012